6,7-Dihydroimidazo[1,5-a]pyridin-8(5H)-one, 95.0%, 100mg

1-Allyl-3-(pyridin-3-yl)thiourea, 95%, 100mg

5-Bromoanthranilic acid, 98.00%, 100g

3-Bromophenylacetonone, 95.0%, 1g

(3R)-3-Dimethylaminopyrrolidine, 95.0%, 1g

Recipiente de reacción con brida plana, cilíndrico, graduado, con camisa de templado y vacío y válvula de drenaje, DN 150, 5000 ml, 250 mm, 1 pieza

2-[2-(4-BROMOPHENYL)-2-OXOETHYL]PROPANEDINITRILE, 95.0%, 1g

2-methylimidazo[1,2-a]pyridine-8-carboxylic acid dihydrochloride hydrate, 95.0%, 1g

1,10-Phenanthroline-5-carboxylic acid, 95.0%, 5g

(R)-tert-Butyl 3-(chloromethyl)pyrrolidine-1-carboxylate, 95.0%, 500mg

2-(2-Fluoro-3,5-dimethylphenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 98%, 5g

3,4-Dihydro-2H-1,5-benzodioxepin-7-amine, 97.0%, 1g

Cyclopropyl phenyl sulfide, 95.0%, 100g